Improving metabolic and cardiovascular health at an Early Psychosis Intervention program in Vancouver, Canada

Improving metabolic and cardiovascular health at an Early Psychosis Intervention program in Vancouver, Canada

Psychotic disorders most commonly appear during the late teenage years and early adulthood. A focused and rapid clinical response by an integrated health team can help to improve the quality of life of the patient, leading to a better long-term prognosis. The Vancouver Coastal Health Early Psychosis...

Full description

Bibliographic Details
Main Authors:	Diane H. Fredrikson, Heidi N. Boyda, Lurdes eTse, Zachary eWhitney, Mark A. Pattison, Fred J. Ott, Laura eHansen, Alasdair M. Barr
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-09-01
Series:	Frontiers in Psychiatry
Subjects:	Exercise Schizophrenia psychosis antipsychotic mental illness Metabolic Syndrome and Diabetes Mellitus
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fpsyt.2014.00105/full

Similar Items

Post-stroke psychosis: how long should we treat?
by: Maria do Céu Ferreira, et al.
Published: (2017-06-01)

Psychosis secondary to thyrotoxicosis that persisted post-thyroidectomy: a case report
by: Shiva Kothari, et al.
Published: (2023-10-01)

Antipsychotic Drugs Efficacy in Dextromethorphan-Induced Psychosis
by: Malgorzata Zaremba, et al.
Published: (2023-01-01)

Antipsychotic prescribing choices in patients with First Episode Psychosis
by: J. Fallon, et al.
Published: (2022-06-01)

Approach to the management of psychosis in Parkinson’s disease
by: Abhishek Lenka, et al.
Published: (2019-01-01)

Course of the Metabolic Syndrome (Mets) in a First Episode Psychosis Sample
by: E. Garcia De Jalon, et al.
Published: (2022-06-01)

Dopamine dilemma: case report of treating psychosis in patient with retinitis pigmentosa
by: Haitham Salem, et al.
Published: (2019-01-01)

Alternative psychosis - Is it a defined clinical entity?
by: Girish H Banwari, et al.
Published: (2013-01-01)

Understanding young peoples’ and family members’ views of treatment for first episode psychosis in a randomised controlled trial (MAPS)
by: R.E. Byrne, et al.
Published: (2020-07-01)

Peripheral Blood Levels of Brain-Derived Neurotrophic Factor in Patients with First Episode Psychosis: A Systematic Review and Meta-Analysis
by: Sukhbir Singh, et al.
Published: (2022-03-01)

The relationship between combined antipsychotic use and clinical features in schizophrenia spectrum patients treated in inpatient ward: A retrospective study
by: U. Baklaci
Published: (2021-04-01)

Schneider’s first-rank symptoms as predictors of remission in antipsychotic-naive first-episode psychosis
by: Fernando R. Malinowski, et al.

Successful Treatment with Lurasidone of First-Episode Psychosis in Down Syndrome: Case Report and Literature Review
by: L. Delgado Montfort
Published: (2022-06-01)

Antipsychotic Treatment Failure: A Systematic Review on Risk Factors and Interventions for Treatment Adherence in Psychosis
by: Kawtar El Abdellati, et al.
Published: (2020-10-01)

Onset of action of atypical and typical antipsychotics in the treatment of acute psychosis
by: Seyed Ghafur Mousavi, et al.
Published: (2013-01-01)

Clozapine Efficacy in a Case of Severe Treatment-Resistant Postpartum Psychosis
by: Teodorescu A, et al.
Published: (2021-02-01)

Clinical Trial Studies of Antipsychotics during Symptomatic Presentations of Agitation and/or Psychosis in Alzheimer’s Dementia: A Systematic Review
by: Haider Qasim, et al.
Published: (2023-06-01)

Case report: 10 years follow-up of psychosis due to Fahr’s disease complicated by a left temporal stroke
by: Marco De Pieri, et al.
Published: (2023-10-01)

Dose Reduction/Discontinuation of Antipsychotic Drugs in Psychosis; Effect on Cognition and Functional Outcomes
by: Yoshie Omachi, et al.
Published: (2018-09-01)

Brain Diffusion Changes in Emerging Psychosis and the Impact of State-Dependent Psychopathology
by: André Schmidt, et al.
Published: (2015-12-01)

Is Obesity in Young People With Psychosis a Foregone Conclusion? Markedly Excessive Energy Intake Is Evident Soon After Antipsychotic Initiation
by: Scott B. Teasdale, et al.
Published: (2018-12-01)

Reducing weight gain in people with schizophrenia, schizoaffective disorder, and first episode psychosis: describing the process of developing the STructured lifestyle Education for People With SchizophrEnia (STEPWISE) intervention
by: Marian E. Carey, et al.
Published: (2018-12-01)

Metabolomic signatures associated with weight gain and psychosis spectrum diagnoses: A pilot study
by: Jiwon Lee, et al.
Published: (2023-04-01)

Implementation of a lifestyle and life-skills intervention to prevent weight-gain and cardiometabolic abnormalities in people with first-episode psychosis: the Keeping the Body in Mind program
by: J. Curtis, et al.
Published: (2022-06-01)

Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel
by: Rajesh Pahwa, et al.
Published: (2022-07-01)

Successful treatment of psychosis in dentatorubral‐pallidoluysian atrophy with quetiapine: A case report
by: Zui Narita, et al.
Published: (2018-03-01)

Long Non-Coding RNAs Associated with Heterochromatin Function in Immune Cells in Psychosis
by: Niyati Sudhalkar, et al.
Published: (2018-12-01)

First-episode psychosis in treatment-resistant schizophrenia: a cross-sectional study of a long-term follow-up cohort
by: Nobuhisa Kanahara, et al.
Published: (2018-09-01)

Voluntary interruption of psychotic pregnancy: Use of antipsychotic drugs in a bioethical case
by: J. Galvañ, et al.
Published: (2021-04-01)

The (ANTI)psychotic paradox: Lewy body dementia
by: J. Galvañ, et al.
Published: (2021-04-01)

Psychotic symptoms in patients with Parkinson's disease: A case report and overview of management
by: Swapnajeet Sahoo, et al.
Published: (2017-01-01)

Monitoring of antipsychotic plasma levels in the assessment of poor response and nonadherence to antipsychotics in delusional disorder
by: A. González-Rodríguez, et al.
Published: (2021-04-01)

Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines
by: Heidi N. Boyda, et al.
Published: (2020-12-01)

Late onset psychosis treatment with adjunctive medicines
by: Irina Boksha, et al.
Published: (2023-12-01)

An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disorders
by: Nadia E. Crellin, et al.
Published: (2022-03-01)

Cariprazine on Psychosis: Beyond Schizophrenia – A Case Series
by: Bajouco M, et al.
Published: (2022-07-01)

Antipsychotic Use in Pregnancy: Patient Mental Health Challenges, Teratogenicity, Pregnancy Complications, and Postnatal Risks
by: Amber N. Edinoff, et al.
Published: (2022-01-01)

An interventional pilot of customized adherence enhancement combined with long-acting injectable antipsychotic medication (CAE-L) for poorly adherent patients with chronic psychotic disorder in Tanzania
by: Jessie Mbwambo, et al.
Published: (2022-01-01)

Physical activity in schizophrenia is higher in the first episode than in subsequent ones
by: Sebastian eWalther, et al.
Published: (2015-01-01)

Challenging the Minimum Effective Antipsychotic Dose During Maintenance: Implications From 10-Year Follow-Up of First Episode Psychosis
by: Chen-Chung Liu, et al.
Published: (2021-09-01)